Fetal and Neonatal Complications Associated With Acute Fatty Liver of Pregnancy

Shumaila J Ahmed1, Sahar Mudassar2, Sana Ali1

  • 1Obstetrics and Gynaecology, Dow University of Health Sciences, Karachi, PAK.

Cureus
|February 23, 2026
PubMed

Background Acute fatty liver of pregnancy (AFLP) is a rare but life-threatening obstetric emergency that can quickly endanger both the mother and fetus, typically presenting in the third trimester. Although greater awareness and supportive management have improved maternal survival, perinatal outcomes remain poor, particularly in resource-limited settings. This study aimed to describe fetal and neonatal complications associated with AFLP and identify maternal factors contributing to poor perinatal outcomes. Methods This retrospective study analysed medical records of 73 women diagnosed with AFLP at the Department of Obstetrics and Gynaecology, Unit I, Dr Ruth K. M. Pfau Civil Hospital Karachi, Dow University of Health Sciences, from November 3, 2024, to April 3, 2025. Diagnosis was based on the Swansea criteria. Maternal demographics, presenting symptoms, laboratory parameters, and neonatal outcomes were reviewed. Poor perinatal outcome was defined as stillbirth, early neonatal death, or a neonatal intensive care unit (NICU) stay exceeding seven days. Multivariate logistic regression was used to identify maternal predictors of adverse outcomes. Results The mean maternal age was 29 years, with most women presenting at an average gestational age of 35 weeks. Nausea and vomiting were reported in 64 (87.7%), malaise in 56 (76.7%), and jaundice in 47 (64.4%). Coagulopathy occurred in 31 (42.5%), while acute kidney injury was noted in 17 (23.3%). There were 13 stillbirths (17.8%) and five early neonatal deaths (6.8%), resulting in a perinatal mortality of 18 (24.6%). Lower gestational age, coagulopathy, and higher maternal bilirubin levels were independently associated with adverse perinatal outcomes. Conclusion Despite improvements in maternal management, perinatal mortality in AFLP remains alarmingly high. Early recognition and timely delivery, ideally before the onset of severe hepatic dysfunction, are critical for improving fetal survival. Strengthening neonatal intensive care facilities, developing national AFLP registries, and establishing standardised management protocols can play a key role in enhancing both maternal and neonatal outcomes in Pakistan and similar settings.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
937
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
784